TY  - JOUR 
AU  - Díez Echave, Patricia
AU  - Vezza, Teresa
AU  - Algieri, Francesca
AU  - Ruiz Malagón, Antonio Jesús
AU  - Hidalgo García, Laura
AU  - García García, Federico
AU  - Morón Romero, María Rocío
AU  - Sánchez Santos, Manuel
AU  - Toral, Marta
AU  - Romero Pérez, Miguel
AU  - Duarte Pérez, Juan Manuel
AU  - Garrido Mesa, José
AU  - Rodríguez Cabezas, María Elena
AU  - Rodríguez Nogales, Alba
AU  - Gálvez Peralta, Julio Juan
PY  - 2022
UR  - http://hdl.handle.net/10481/76707
AB  - Background and purpose: Melatonin has shown beneficial effects on obesity, both in humans and experimental
models, via regulating the altered circadian rhythm and thus ameliorating the gut dysbiosis associated with this
metabolic condition. However,...
LA  - eng
PB  - Elsevier
KW  - Agomelatine
KW  - Melatonin
KW  - Metabolism
KW  - Metformin
KW  - Microbiome
KW  - Obesity
TI  - The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome
DO  - 10.1016/j.biopha.2022.113445
ER  -